Frank E. Mott, MD, FACP
Present Title & Affiliation
Clinical trials looking at treatment and prevention of HPV-associated head and neck cancers, targeted therapies in combination with chemotherapy and/or radiotherapy, quality patient reported outcomes in thoracic and head and neck cancers, palliative care interventions and end-of-life management in thoracic and head and neck cancer patients.
Head and neck cancers including HPV-associated tumors; anaplastic thyroid cancers, and nasopharyngeal cancers.
Thoracic cancers including mesothelioma.
Education & Training
|1988||Texas A&M University, College of Medicine, Bryan, TX, MD, Medical Oncology|
|1980||University of Texas College of Pharmacy, Austin, TX, BS, Pharmacy|
|7/1991-6/1994||Hem-Onc Fellowship, Hem-Onc Fellowship, University of Wisconsin, Madison, WI|
|7/1988-6/1991||Internal medicine Residency, University of Wisconsin, Madison, WI|
Peer-Reviewed Original Research Articles
|1.||Marcus JD, Mott FE. Difficult conversations: from diagnosis to death. Ochsner J 14(4):712-7, 2014. PMCID: PMC4295750.|
|2.||Bansal M, Boyle T, Ehsan A, Mott FE. Brain metastases in N2-positive non-small-cell lung cancer: implications for prophylactic cranial irradiation. Clin Lung Cancer (9)4:227-9, 7/2008. PMID: 18650171.|
|3.||Mott FE, Esana A, Chakmakjian C, Herrington JD. Tumor lysis syndrome in solid tumors. Support Cancer Ther 2(3):188-91, 4/1/2005. PMID: 18628171.|
|4.||Mott FE, Sharma N, Ashley P. Malignant pleural effusion in non-small cell lung cancer--time for a stage revision? Chest 119(1):317-8, 1/2001. PMID: 11157634.|
|5.||Zhao J, Yingfeng XY, Kaminski J, Hao Z, Mott F, Campbell J, Sade R, Kong FM. Treatment-related death during concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: A meta-analysis of randomized studies, submitted October 2015. Radiation Oncology. Submitted.|
|1.||Mott FE. Prescription for health cost reduction: an editorial. J La State Med Soc 164:125-126, 5/2012.|
|1.||Zhao J, Kong FM, Hao Z, Mott F, Al-Basheer A, Dasher B, Mourad W, Kaminski J, Zaenger D, Rabatic B, Ye P, Howington J, Ferguson C. Risk factors for non-small cell lung cancer survival from Georgia Regents University tumor registry in 12 years. ASCO 2015, 2015.|
|2.||Rixe O, Munn D, Mott F, Johnson T, Colman H, Spira A, Sadek R, Zakharia Y, Kennedy G. Updates on Phar 1b/2 combination study of the IDO pathway inhibitor indoximod with temozolomide for adult patients with temozolomid-refractory primary malignant brain tumors. Abstrace, SNO 2015, Neuro-Oncology 17:v107-v112, 2015.|
|3.||El-Osta B, Sumrall B, Marcus J, Mott F. A survey to evaluate our physician-trainees' comfort and knowledge in communicating their final good-bye to their terminally ill patient. J Clin Oncol 32, suppl 31 (#114), 10/2014.|
|4.||Yan B, Abbas A, Mott FE. Robotic-assisted thoracoscopies in early stage lung cancer: A single institution experience. Inagural Thoracic Malignancies Conference, Ochsner Clinic, New Orleans, LA, 6/2011.|
|1.||Mott FE. Mesothelioma: a review. In: Ochsner J. 12, 1, 70-9, 2012. PMCID: PMC3307510.|
|2.||Mott FE, Chakmakjian C, Marcus J. The Multidisciplinary Management of Pain and Palliative Care in Cancer Patients: A Review. In: Cancer Therapy. 2, 365-74, 2004.|
Last updated: 7/28/2016